BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37753113)

  • 1. Zebrafish as model system for the biological characterization of CK1 inhibitors.
    Meier L; Gahr BM; Roth A; Gihring A; Kirschner S; Woitaske-Proske C; Baier J; Peifer C; Just S; Knippschild U
    Front Pharmacol; 2023; 14():1245246. PubMed ID: 37753113
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
    Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
    Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of Inhibitor of Wnt Production 2 (IWP-2) and Related Compounds As Selective ATP-Competitive Inhibitors of Casein Kinase 1 (CK1) δ/ε.
    García-Reyes B; Witt L; Jansen B; Karasu E; Gehring T; Leban J; Henne-Bruns D; Pichlo C; Brunstein E; Baumann U; Wesseler F; Rathmer B; Schade D; Peifer C; Knippschild U
    J Med Chem; 2018 May; 61(9):4087-4102. PubMed ID: 29630366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CK1 gene family: expression patterning in zebrafish development.
    Albornoz A; Yáñez JM; Foerster C; Aguirre C; Pereiro L; Burzio V; Moraga M; Reyes AE; Antonelli M
    Biol Res; 2007; 40(2):251-66. PubMed ID: 18064361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CK1δ/ϵ-Tip60 Axis Enhances Wnt/β-Catenin Signaling
    Ning J; Sun Q; Su Z; Tan L; Tang Y; Sayed S; Li H; Xue VW; Liu S; Chen X; Lu D
    Front Oncol; 2022; 12():844477. PubMed ID: 35494070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Casein kinase 1α has a non-redundant and dominant role within the CK1 family in melanoma progression.
    Sinnberg T; Wang J; Sauer B; Schittek B
    BMC Cancer; 2016 Aug; 16():594. PubMed ID: 27488834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
    Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
    Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CK1δ in lymphoma: gene expression and mutation analyses and validation of CK1δ kinase activity for therapeutic application.
    Winkler BS; Oltmer F; Richter J; Bischof J; Xu P; Burster T; Leithäuser F; Knippschild U
    Front Cell Dev Biol; 2015; 3():9. PubMed ID: 25750912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Advances in the Development of Casein Kinase 1 Inhibitors.
    Li SS; Dong YH; Liu ZP
    Curr Med Chem; 2021; 28(8):1585-1604. PubMed ID: 32660395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
    Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
    Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders.
    Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V
    Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural Investigations on 2-Amidobenzimidazole Derivatives as New Inhibitors of Protein Kinase CK1 Delta.
    Calenda S; Catarzi D; Varano F; Vigiani E; Volpini R; Lambertucci C; Spinaci A; Trevisan L; Grieco I; Federico S; Spalluto G; Novello G; Salmaso V; Moro S; Colotta V
    Pharmaceuticals (Basel); 2024 Apr; 17(4):. PubMed ID: 38675428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CK1δ: a pharmacologically tractable Achilles' heel of Wnt-driven cancers?
    Cheong JK; Virshup DM
    Ann Transl Med; 2016 Nov; 4(21):433. PubMed ID: 27942524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Casein kinase 1δ activity: a key element in the zebrafish circadian timing system.
    Smadja Storz S; Tovin A; Mracek P; Alon S; Foulkes NS; Gothilf Y
    PLoS One; 2013; 8(1):e54189. PubMed ID: 23349822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of Potent and Exquisitely Selective Inhibitors of Kinase CK1 with Tunable Isoform Selectivity.
    Němec V; Khirsariya P; Janovská P; Moyano PM; Maier L; Procházková P; Kebková P; Gybel' T; Berger BT; Chaikuad A; Reinecke M; Kuster B; Knapp S; Bryja V; Paruch K
    Angew Chem Int Ed Engl; 2023 Mar; 62(11):e202217532. PubMed ID: 36625768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longdaysin inhibits Wnt/β-catenin signaling and exhibits antitumor activity against breast cancer.
    Xiong Y; Zhou L; Su Z; Song J; Sun Q; Liu SS; Xia Y; Wang Z; Lu D
    Onco Targets Ther; 2019; 12():993-1005. PubMed ID: 30787621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difluoro-dioxolo-benzoimidazol-benzamides as potent inhibitors of CK1δ and ε with nanomolar inhibitory activity on cancer cell proliferation.
    Richter J; Bischof J; Zaja M; Kohlhof H; Othersen O; Vitt D; Alscher V; Pospiech I; García-Reyes B; Berg S; Leban J; Knippschild U
    J Med Chem; 2014 Oct; 57(19):7933-46. PubMed ID: 25191940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes.
    Meng QJ; Maywood ES; Bechtold DA; Lu WQ; Li J; Gibbs JE; Dupré SM; Chesham JE; Rajamohan F; Knafels J; Sneed B; Zawadzke LE; Ohren JF; Walton KM; Wager TT; Hastings MH; Loudon AS
    Proc Natl Acad Sci U S A; 2010 Aug; 107(34):15240-5. PubMed ID: 20696890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression levels of Casein kinase 1 (CK1) isoforms are correlated to adiponectin levels in adipose tissue of morbid obese patients and site-specific phosphorylation mediated by CK1 influences multimerization of adiponectin.
    Xu P; Fischer-Posovszky P; Bischof J; Radermacher P; Wabitsch M; Henne-Bruns D; Wolf AM; Hillenbrand A; Knippschild U
    Mol Cell Endocrinol; 2015 May; 406():87-101. PubMed ID: 25724478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.